[ASSOCIATION OF 2 ANTIDIABETIC DRUGS FOR ORAL USE WITH AMP, THIAMINE AND VITAMIN B 12 IN THE TREATMENT OF DIABETIC POLYNEURITIS].
D000227:Adenine Nucleotides; D000249:Adenosine Monophosphate; D001798:Blood Proteins; D002784:Cholesterol / Q000097:blood*; D003929:Diabetic Neuropathies; D006023:Glycoproteins; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D009443:Neuritis; D011773:Pyruvates; D013831:Thiamine; D014805:Vitamin B 12
D000227:Adenine Nucleotides; D001798:Blood Proteins; D006023:Glycoproteins; D007004:Hypoglycemic Agents; D008055:Lipids; D008074:Lipoproteins; D011773:Pyruvates; D000249:Adenosine Monophosphate; D002784:Cholesterol; D014805:Vitamin B 12; D013831:Thiamine
ADENINE NUCLEOTIDES; ANTIDIABETICS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BLOOD PROTEINS; DIABETIC NEUROPATHIES; GLYCOPROTEINS; GLYCOSURIA; LIPOPROTEINS; PYRUVATES; VITAMIN B 12
ASSOCIAZIONE DI DUE FARMACI ANTIDIABETICI AD USO ORALE CON AMP, TIAMINA E VITAMINA B 12 NELLA CURA DELLA POLINEVRITE DIABETICA.